FLT1: a potential therapeutic target in sepsis-associated ARDS?

Lancet Respir Med. 2020 Mar;8(3):219-220. doi: 10.1016/S2213-2600(19)30404-7. Epub 2020 Jan 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dyspnea
  • Genome-Wide Association Study
  • Humans
  • Respiratory Distress Syndrome*
  • Sepsis*
  • Vascular Endothelial Growth Factor Receptor-1

Substances

  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1